Table 3 Univariable analysis of 30-day all-cause mortality
Parameter | Died (n = 71) | Survived (n = 53) | P-value | |
|---|---|---|---|---|
n (%) OR Median [IQR] | ||||
NCBL antibiotics use | 57 (80.3) | 41 (77.4) | 0.692 | |
NVL antibiotics use | 14 (19.7) | 12 (22.6) | ||
Age (years) | 62 [43, 77] | 64 [49, 77] | 0.705 | |
Carlson Comorbidity Index score | 5 [2, 6] | 6 [3, 7] | 0.260 | |
Immunocompromised | 23 (43.4) | 31 (43.7) | 0.976 | |
ICU admission | 42 (59.2) | 42 (79.3) | 0.018* | |
Vasopressors use | 15 (21.1) | 29 (54.7) | < 0.001* | |
APACHE II score | 17 [12, 21] | 20 [15, 25] | 0.020* | |
Infection type | ||||
-Hospital/Ventilator acquired pneumonia | 36 (67.9) | 40 (56.3) | 0.190 | |
-Urinary tract infection | 17 (23.9) | 6 (11.3) | 0.074 | |
-Wound | 14 (19.7) | 10 (18.9) | 0.906 | |
-Intraabdominal | 2 (2.8) | 1 (1.9) | 0.739 | |
-Other | 4 (5.6) | 4 (7.6) | 0.668 | |
Duration of definitive therapy (days) | 7 [5, 12] | 8 [6, 11] | 0.460 | |
Infusion type | ||||
-Intermittent infusion | 56 (78.9) | 38 (71.7) | 0.356 | |
-Extended infusion | 15 (21.1) | 15 (28.3) | ||